Cargando…
Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia
AIMS/HYPOTHESIS: We aimed to characterise the immunogenic background of insulin-dependent diabetes in a resource-poor rural African community. The study was initiated because reports of low autoantibody prevalence and phenotypic differences from European-origin cases with type 1 diabetes have raised...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476916/ https://www.ncbi.nlm.nih.gov/pubmed/32705316 http://dx.doi.org/10.1007/s00125-020-05229-x |
_version_ | 1783579793158045696 |
---|---|
author | Balcha, Shitaye A. Demisse, Abayneh G. Mishra, Rajashree Vartak, Tanwi Cousminer, Diana L. Hodge, Kenyaita M. Voight, Benjamin F. Lorenz, Kim Schwartz, Stanley Jerram, Samuel T. Gamper, Arla Holmes, Alice Wilson, Hannah F. Williams, Alistair J. K. Grant, Struan F. A. Leslie, R. David Phillips, David I. W. Trimble, Elisabeth R. |
author_facet | Balcha, Shitaye A. Demisse, Abayneh G. Mishra, Rajashree Vartak, Tanwi Cousminer, Diana L. Hodge, Kenyaita M. Voight, Benjamin F. Lorenz, Kim Schwartz, Stanley Jerram, Samuel T. Gamper, Arla Holmes, Alice Wilson, Hannah F. Williams, Alistair J. K. Grant, Struan F. A. Leslie, R. David Phillips, David I. W. Trimble, Elisabeth R. |
author_sort | Balcha, Shitaye A. |
collection | PubMed |
description | AIMS/HYPOTHESIS: We aimed to characterise the immunogenic background of insulin-dependent diabetes in a resource-poor rural African community. The study was initiated because reports of low autoantibody prevalence and phenotypic differences from European-origin cases with type 1 diabetes have raised doubts as to the role of autoimmunity in this and similar populations. METHODS: A study of consecutive, unselected cases of recently diagnosed, insulin-dependent diabetes (n = 236, ≤35 years) and control participants (n = 200) was carried out in the ethnic Amhara of rural North-West Ethiopia. We assessed their demographic and socioeconomic characteristics, and measured non-fasting C-peptide, diabetes-associated autoantibodies and HLA-DRB1 alleles. Leveraging genome-wide genotyping, we performed both a principal component analysis and, given the relatively modest sample size, a provisional genome-wide association study. Type 1 diabetes genetic risk scores were calculated to compare their genetic background with known European type 1 diabetes determinants. RESULTS: Patients presented with stunted growth and low BMI, and were insulin sensitive; only 15.3% had diabetes onset at ≤15 years. C-peptide levels were low but not absent. With clinical diabetes onset at ≤15, 16–25 and 26–35 years, 86.1%, 59.7% and 50.0% were autoantibody positive, respectively. Most had autoantibodies to GAD (GADA) as a single antibody; the prevalence of positivity for autoantibodies to IA-2 (IA-2A) and ZnT8 (ZnT8A) was low in all age groups. Principal component analysis showed that the Amhara genomes were distinct from modern European and other African genomes. HLA-DRB1*03:01 (p = 0.0014) and HLA-DRB1*04 (p = 0.0001) were positively associated with this form of diabetes, while HLA-DRB1*15 was protective (p < 0.0001). The mean type 1 diabetes genetic risk score (derived from European data) was higher in patients than control participants (p = 1.60 × 10(−7)). Interestingly, despite the modest sample size, autoantibody-positive patients revealed evidence of association with SNPs in the well-characterised MHC region, already known to explain half of type 1 diabetes heritability in Europeans. CONCLUSIONS/INTERPRETATION: The majority of patients with insulin-dependent diabetes in rural North-West Ethiopia have the immunogenetic characteristics of autoimmune type 1 diabetes. Phenotypic differences between type 1 diabetes in rural North-West Ethiopia and the industrialised world remain unexplained. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-020-05229-x) contains peer-reviewed but unedited supplementary material, which is available to authorised users. |
format | Online Article Text |
id | pubmed-7476916 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-74769162020-09-21 Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia Balcha, Shitaye A. Demisse, Abayneh G. Mishra, Rajashree Vartak, Tanwi Cousminer, Diana L. Hodge, Kenyaita M. Voight, Benjamin F. Lorenz, Kim Schwartz, Stanley Jerram, Samuel T. Gamper, Arla Holmes, Alice Wilson, Hannah F. Williams, Alistair J. K. Grant, Struan F. A. Leslie, R. David Phillips, David I. W. Trimble, Elisabeth R. Diabetologia Article AIMS/HYPOTHESIS: We aimed to characterise the immunogenic background of insulin-dependent diabetes in a resource-poor rural African community. The study was initiated because reports of low autoantibody prevalence and phenotypic differences from European-origin cases with type 1 diabetes have raised doubts as to the role of autoimmunity in this and similar populations. METHODS: A study of consecutive, unselected cases of recently diagnosed, insulin-dependent diabetes (n = 236, ≤35 years) and control participants (n = 200) was carried out in the ethnic Amhara of rural North-West Ethiopia. We assessed their demographic and socioeconomic characteristics, and measured non-fasting C-peptide, diabetes-associated autoantibodies and HLA-DRB1 alleles. Leveraging genome-wide genotyping, we performed both a principal component analysis and, given the relatively modest sample size, a provisional genome-wide association study. Type 1 diabetes genetic risk scores were calculated to compare their genetic background with known European type 1 diabetes determinants. RESULTS: Patients presented with stunted growth and low BMI, and were insulin sensitive; only 15.3% had diabetes onset at ≤15 years. C-peptide levels were low but not absent. With clinical diabetes onset at ≤15, 16–25 and 26–35 years, 86.1%, 59.7% and 50.0% were autoantibody positive, respectively. Most had autoantibodies to GAD (GADA) as a single antibody; the prevalence of positivity for autoantibodies to IA-2 (IA-2A) and ZnT8 (ZnT8A) was low in all age groups. Principal component analysis showed that the Amhara genomes were distinct from modern European and other African genomes. HLA-DRB1*03:01 (p = 0.0014) and HLA-DRB1*04 (p = 0.0001) were positively associated with this form of diabetes, while HLA-DRB1*15 was protective (p < 0.0001). The mean type 1 diabetes genetic risk score (derived from European data) was higher in patients than control participants (p = 1.60 × 10(−7)). Interestingly, despite the modest sample size, autoantibody-positive patients revealed evidence of association with SNPs in the well-characterised MHC region, already known to explain half of type 1 diabetes heritability in Europeans. CONCLUSIONS/INTERPRETATION: The majority of patients with insulin-dependent diabetes in rural North-West Ethiopia have the immunogenetic characteristics of autoimmune type 1 diabetes. Phenotypic differences between type 1 diabetes in rural North-West Ethiopia and the industrialised world remain unexplained. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-020-05229-x) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2020-07-23 2020 /pmc/articles/PMC7476916/ /pubmed/32705316 http://dx.doi.org/10.1007/s00125-020-05229-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Balcha, Shitaye A. Demisse, Abayneh G. Mishra, Rajashree Vartak, Tanwi Cousminer, Diana L. Hodge, Kenyaita M. Voight, Benjamin F. Lorenz, Kim Schwartz, Stanley Jerram, Samuel T. Gamper, Arla Holmes, Alice Wilson, Hannah F. Williams, Alistair J. K. Grant, Struan F. A. Leslie, R. David Phillips, David I. W. Trimble, Elisabeth R. Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia |
title | Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia |
title_full | Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia |
title_fullStr | Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia |
title_full_unstemmed | Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia |
title_short | Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia |
title_sort | type 1 diabetes in africa: an immunogenetic study in the amhara of north-west ethiopia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476916/ https://www.ncbi.nlm.nih.gov/pubmed/32705316 http://dx.doi.org/10.1007/s00125-020-05229-x |
work_keys_str_mv | AT balchashitayea type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia AT demisseabaynehg type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia AT mishrarajashree type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia AT vartaktanwi type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia AT cousminerdianal type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia AT hodgekenyaitam type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia AT voightbenjaminf type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia AT lorenzkim type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia AT schwartzstanley type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia AT jerramsamuelt type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia AT gamperarla type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia AT holmesalice type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia AT wilsonhannahf type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia AT williamsalistairjk type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia AT grantstruanfa type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia AT leslierdavid type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia AT phillipsdavidiw type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia AT trimbleelisabethr type1diabetesinafricaanimmunogeneticstudyintheamharaofnorthwestethiopia |